Inductive Bio has officially launched Indy, an advanced artificial intelligence chemistry assistant designed to double the operational capacity of medicinal chemists across drug discovery initiatives. Developed directly by Inductive Bio’s internal team of medicinal chemists, computational chemists, and DMPK experts, Indy has already demonstrated a two-fold boost in internal team productivity across ongoing partner projects.
Eliminating Bottlenecks in Drug Discovery
However, it is actually the laborious, manual data analysis and decision making process that takes years to complete which is the main roadblock. Important queries such as validation of assay data, understanding SARs, formulation of TPPs, optimization of reaction pathways, and synthesis goals take up the major portion of the work schedule of the medicinal chemist and any mistakes can halt the project by months.Indy directly resolves this operational constraint by elevating the speed and precision of every decision.
The AI assistant automates repetitive workflows, including:
- Parsing CRO reports and quality-checking (QC) dose-response curves.
- Analyzing historical SAR to surface actionable insights and patterns.
- Executing generative chemistry algorithms and configuring Free Energy Perturbation (FEP) calculations.
- Generating project update presentations for upcoming cross-functional meetings.
By handling data management and preliminary analysis, Indy enables scientists to allocate their time toward higher-value strategic research.
Also Read: Bayer and Henry Ford Health Form Strategic Research Alliance to Accelerate Clinical Trial Access
Benchmark Performance: Outperforming Leading LLMs
In a head-to-head benchmark evaluation analyzing 84 dose-response curves from active discovery programs, Indy significantly outperformed general-purpose frontier AI models.
| AI Model / Assistant | Accuracy Rate |
| Indy (Inductive Bio) | 89% |
| Claude Opus 5 | 48% |
| GPT-5.6 Sol | 39% |
Even when general-purpose models were configured to run at maximum reasoning and effort parameters, Indy demonstrated superior precision in technical chemistry tasks.
Executive Commentary
“We have incorporated Indy into a number of workflows, including data QC, SAR table construction and analysis, and synthesis queue management,” said Nicholas Perl, PhD, head of chemistry at Anvia Therapeutics. “Indy surfaces patterns in the data that help us make better decisions, and it lets me spend less time maintaining slides and more time driving scientific strategy.”
“We trained Indy on the tasks that take medicinal chemists’ time but not their creativity,” said Josh Haimson, co-founder and CEO of Inductive Bio. “The result is an assistant that can double a chemist’s productivity while fitting seamlessly into their existing workflows.”
